Mark Edward Spring's most recent trade in Artelo Biosciences Inc was a trade of 36,391 Stock Options (right to buy) done . Disclosure was reported to the exchange on Jan. 29, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Artelo Biosciences Inc | Mark Edward Spring | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jan 2026 | 36,391 | 36,391 | - | - | Stock Options (right to buy) |